Nasdaq IPOs

Jaws Acquisition, a blank check company led by Starwood Capital founder Barry Sternlicht, filed on Tuesday with the SEC to raise up to $400 million in an initial public offering. The Miami Beach, FL-based company plans to raise $400 million by offering 40 million units at $10. Ea

Jaws Acquisition, a blank check company led by Starwood Capital founder Barry Sternlicht, filed on Tuesday with the SEC to raise up to $400 million in an initial public offering. The Miami Beach, FL-based company plans to raise $400 million by offering 40 million units at $10. Ea

IPOs are leading the stock market's recovery. The Renaissance IPO Index has soared 42.6% from its mid-March low, compared to a 28.9% rebound for the S&P 500. The IPO Index, which is composed of the largest and most liquid IPOs over the past two years and tracked by the IPO ET

IPOs are leading the stock market's recovery. The Renaissance IPO Index has soared 42.6% from its mid-March low, compared to a 28.9% rebound for the S&P 500. The IPO Index, which is composed of the largest and most liquid IPOs over the past two years and tracked by the IPO ET

Social Capital Hedosophia Holdings II, the second blank check company formed by Social Capital and Hedosophia targeting a US tech business, raised $360 million by offering 36 million units at $10. The company raised $60 million more than expected. Each unit consists of one share

TRX Insurance Brokers, a Chinese insurance brokerage with a network of 40 insurers, announced terms for its IPO on Monday. The Beijing, China-based company plans to raise $13 million by offering 3 million shares at a price range of $4.00 to $4.50. At the midpoint of the proposed

Latest SPAC: Eklavya Saraf, Nasdaq’s global head of SPAC listings, goes behind Friday morning’s virtual Nasdaq Opening Bell, sharing his insight on how DraftKings tapped the public markets.

Lyra Therapeutics, a Phase 2 biotech developing an implantable drug matrix for chronic rhinosinusitis, announced terms for its IPO on Monday. The Watertown, MA-based company plans to raise $53 million by offering 3.5 million shares at a price range of $14 to $16. At the midpoint

GAN Limited, a UK-based provider of internet gambling software, announced terms for its IPO on Monday. The London, United Kingdom-based company plans to raise $30 million by offering 4.1 million shares at a price range of $6.50 to $8.50. At the midpoint of the proposed range, GAN

GAN Limited, a UK-based provider of internet gambling software, announced terms for its IPO on Monday. The London, United Kingdom-based company plans to raise $30 million by offering 4.1 million shares at a price range of $6.50 to $8.50. At the midpoint of the proposed range, GAN

Updated on 4/27/2020. One biotech and two SPACs are on the calendar for the week ahead. The IPO market is showing some early signs of opening up. Recent biotech IPOs have had strong debuts, SPAC activity has picked up, and a few deals in the pipeline like Albertsons (ACI) and Kin

Updated on 4/27/2020. One biotech is on the calendar for the week ahead. The IPO market is showing some early signs of opening up. Recent biotech IPOs have had strong debuts, SPAC activity has picked up, and a few deals in the pipeline like Albertsons (ACI) and Kingsoft (KC) have

There are no IPOs scheduled for the week ahead, but the IPO market is showing some early signs of opening up. Recent biotech IPOs have had strong debuts, SPAC activity has picked up, and a few deals in the pipeline like Albertsons (ACI) and Kingsoft (KC) have signaled potential M

The IPO market saw a jump in activity as one biotech and three SPACs went public this past week. The durability of the biotech industry was demonstrated once again, with ORIC Pharmaceuticals (ORIC) popping 61% on its first day. Four IPOs and one SPAC submitted initial filings. O

ADC Therapeutics, a Swiss Phase 2 biotech developing next-gen antibody drug conjugates for difficult cancers, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The company previously filed to raise $200 million in September 2019 but withdrew

ADC Therapeutics, a Swiss Phase 2 biotech developing next-gen antibody drug conjugates for difficult cancers, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The company filed previously in September 2019 before withdrawing its S1 later in

Ebang International Holdings, which makes equipment for cryptocurrency mining in China, filed on Friday with the SEC to raise up to $100 million in an initial public offering. Ebang designs application-specific integrated circuit (ASIC) chips and fabless integrated circ

The IPO market saw a jump in activity as one biotech and three SPACs went public this past week. The durability of the biotech industry was demonstrated once again, with ORIC Pharmaceuticals (ORIC) popping 61% on its first day. Four companies and one SPAC submitted initial filing

SeqLL, which provides a genetic sequencing platform for researching the makeup of diseases, withdrew its plans for an initial public offering on Friday. It had originally filed in April 2019 to raise $8 million by offering 1.4 million shares at a price range of $5.40 to $6.40. Th

Diamond Eagle Acquisition, the fifth blank check company formed by entertainment veteran Jeff Sagansky, completed its previously-announced acquisition of DraftKings. The newly combined company began trading on the Nasdaq on Friday under the symbol DKNG, with an expected market ca